annexure ii
ANNEXURE E: Risk assessment forms - TB-IPCP
Annexure A - AGHS Foundation Option 2016
Annex: The WHO Global Salm-Surv
Annex XII: (10/25/01) IACUC Policy For Postoperative Surgical Care
ANNEX III SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX III Acronyms and abbreviations used in - EMA
Annex II. Listing of oxygen medicinal gas in the WHO Model Formulary
Annex I: Final CSP Fluconazol 4.3 Contraindications Fluconazole
Annex I: CSP
ANNEX I PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANTS / MARKETING
Annex I : CSP
Annex B – Basic Level Training
ANNEX A3 DMHAS ENHANCEMENT PACKAGES SERVICE
ANNEX A –INVISALIGN TECHNIQUE GENERAL INFORMATIONS
Annex 9 Guide to good storage practices for pharmaceuticals1
Annex 4. Proposed non-occupational exposure report
Annex 4 Vaccine Adverse Event Reporting
Annex 3 Guidelines for Large Scale Smallpox Vaccination Clinics
Annex 1: Technical report on MDPV - Emcdda
